BDX · 10-Q · 2026Q2 · Full report

China Healthcare Cost Controls

BECTON DICKINSON & CO · 2026-08-06 · Importance 29 · Surprise 24

BD reported adverse effects from China market dynamics, including volume-based procurement programs (VoBP) and government efforts to contain healthcare costs and improve healthcare-practitioner compliance. These factors primarily affected the Medical Essentials segment’s Medication Delivery Solutions unit and the Interventional segment’s Peripheral Intervention unit, while contributing to a decline in emerging-market revenue in China during the third quarter of fiscal 2026. Lower vaccine demand and potential deterioration in healthcare-system budgets also reduced demand for BD products and services.